Research Journal of Medical Sciences
ISSN: Online 1993-6095ISSN: Print 1815-9346
Abstract
The second most frequent cancer in women and the third most prevalent in males is colorectal cancer. It is the third most common cause of newly diagnosed cancer cases and cancer-related deaths in the US, affecting both men and women equally. The aims to determine the accuracy of Digital rectal examination (DRE) and M.RI of Pelvis to measure tumor height (Distance of distal end of tumor from anal verge) in rectal cancer cases in respect to actual height measured in operated specimen after specific surgical Procedure. This descriptive, Cross sectional study was conducted in Department of General surgery, Dept. Radio-diagnosis and Dept. of Pathology of Bankura Sammilani Medical College and hospital, Bankura, West Bengal, India from January 2020 to June 2021. The mean Duration of Rectal Symptoms (Days) (Mean±S.D) of patients was 145.9545±105.3839. The mean Digital Rectal Examination (Mean±S.D) of patients was 4.0015±0.6090. The mean MRI (Mean±S.D) of patients was 4.6989±0.7400. The mean Operated Specimen (Mean±S.D) of patients was 4.3152±0.6315. To sum up, there is a great deal of variation and association between the tumor height measurements made for rectal malignancies using digital rectal examination (DRE), magnetic resonance imaging (MRI) and analysis of surgical material. MRI offers a more accurate and non-invasive evaluation than DRE, which has limitations related to tumor location and examiner variability. As DRE is also comparable with operated specimen, (though it is less sensitive than MRI), may be used in pre-operative planning in poorly served areas where MRI is not available.
How to cite this article:
Sanjib Kundu, Paran Tudu and Saurabh Garai. Study of Tumor Height in Rectal Cancers According to Digital Rectal Examination, M.R.I and Operated Specimen.
DOI: https://doi.org/10.36478/10.59218/makrjms.2024.3.18.465.469
URL: https://www.makhillpublications.co/view-article/1815-9346/10.59218/makrjms.2024.3.18.465.469